Wei L, Berman Y, Castaño E M, Cadene M, Beavis R C, Devi L, Levy E
Departments of Pharmacology and Pathology, New York University Medical Center, New York, New York 10016, USA.
J Biol Chem. 1998 May 8;273(19):11806-14. doi: 10.1074/jbc.273.19.11806.
A cystatin C variant with L68Q substitution and a truncation of 10 NH2-terminal residues is the major constituent of the amyloid deposited in the cerebral vasculature of patients with the Icelandic form of hereditary cerebral hemorrhage with amyloidosis (HCHWA-I). Variant and wild type cystatin C production, processing, secretion, and clearance were studied in human cell lines stably overexpressing the cystatin C genes. Immunoblot and mass spectrometry analyses demonstrated monomeric cystatin C in cell homogenates and culture media. While cystatin C formed concentration-dependent dimers, the HCHWA-I variant dimerized at lower concentrations than the wild type protein. Amino-terminal sequence analysis revealed that the variant and normal proteins produced and secreted are the full-length cystatin C. Pulse-chase experiments demonstrated similar levels of normal and variant cystatin C production and secretion. However, the secreted variant cystatin C exhibited an increased susceptibility to a serine protease in conditioned media and in human cerebrospinal fluid, explaining its depletion from the cerebrospinal fluid of HCHWA-I patients. Thus, the amino acid substitution may induce unstable cystatin C with intact inhibitory activity and predisposition to self-aggregation and amyloid fibril formation.
一种具有L68Q替代且N端截短10个残基的胱抑素C变体是冰岛型遗传性脑出血伴淀粉样变性(HCHWA-I)患者脑脉管系统中沉积的淀粉样蛋白的主要成分。在稳定过表达胱抑素C基因的人细胞系中研究了变体和野生型胱抑素C的产生、加工、分泌及清除。免疫印迹和质谱分析表明在细胞匀浆和培养基中存在单体胱抑素C。虽然胱抑素C形成浓度依赖性二聚体,但HCHWA-I变体比野生型蛋白在更低浓度下形成二聚体。N端序列分析显示产生和分泌的变体蛋白与正常蛋白均为全长胱抑素C。脉冲追踪实验表明正常和变体胱抑素C的产生及分泌水平相似。然而,分泌的变体胱抑素C在条件培养基和人脑脊液中对丝氨酸蛋白酶的敏感性增加,这解释了其在HCHWA-I患者脑脊液中的消耗。因此,氨基酸替代可能诱导具有完整抑制活性但易于自我聚集和形成淀粉样纤维的不稳定胱抑素C。